Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$5.67 - $8.06 $1,791 - $2,546
-316 Reduced 62.82%
187 $1,000
Q1 2024

Apr 25, 2024

SELL
$6.63 - $10.69 $31,134 - $50,200
-4,696 Reduced 90.33%
503 $4,000
Q4 2023

Feb 02, 2024

BUY
$3.61 - $7.76 $18,768 - $40,344
5,199 New
5,199 $35,000
Q2 2022

Aug 03, 2022

SELL
$6.99 - $10.0 $64,273 - $91,950
-9,195 Closed
0 $0
Q1 2022

May 02, 2022

BUY
$7.26 - $10.7 $34,245 - $50,471
4,717 Added 105.34%
9,195 $73,000
Q4 2021

Feb 23, 2022

BUY
$8.8 - $16.0 $39,406 - $71,648
4,478 New
4,478 $41,000
Q2 2021

Aug 12, 2021

SELL
$17.8 - $23.5 $43,467 - $57,387
-2,442 Closed
0 $0
Q1 2021

Apr 26, 2021

SELL
$17.18 - $22.6 $67,465 - $88,750
-3,927 Reduced 61.66%
2,442 $49,000
Q4 2020

Feb 02, 2021

BUY
$11.5 - $17.96 $73,243 - $114,387
6,369 New
6,369 $114,000
Q2 2020

Jul 13, 2020

SELL
$7.35 - $10.81 $20,381 - $29,976
-2,773 Closed
0 $0
Q1 2020

Apr 29, 2020

SELL
$8.38 - $17.34 $105,814 - $218,952
-12,627 Reduced 81.99%
2,773 $28,000
Q4 2019

Feb 05, 2020

BUY
$11.18 - $18.6 $172,172 - $286,440
15,400 New
15,400 $275,000
Q3 2019

Oct 15, 2019

SELL
$12.09 - $20.46 $17,155 - $29,032
-1,419 Closed
0 $0
Q2 2019

Jul 26, 2019

BUY
$18.5 - $25.47 $13,468 - $18,542
728 Added 105.35%
1,419 $28,000
Q1 2019

Apr 18, 2019

SELL
$14.62 - $22.13 $21,272 - $32,199
-1,455 Reduced 67.8%
691 $0
Q4 2018

Jan 16, 2019

SELL
$17.09 - $38.25 $75,589 - $169,179
-4,423 Reduced 67.33%
2,146 $43,000
Q3 2018

Oct 23, 2018

BUY
$34.05 - $55.9 $187,513 - $307,841
5,507 Added 518.55%
6,569 $242,000
Q2 2018

Jul 30, 2018

SELL
$36.15 - $52.5 $54,152 - $78,645
-1,498 Reduced 58.52%
1,062 $53,000
Q1 2018

Apr 26, 2018

SELL
$24.4 - $40.25 $420,485 - $693,628
-17,233 Reduced 87.07%
2,560 $93,000
Q4 2017

Jan 10, 2018

BUY
$18.5 - $28.6 $366,170 - $566,079
19,793
19,793 $560,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $763M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.